Meanwhile, despite advances in the treatment strategy for heart failure, such as evidence-based approaches to treat heart failure risk factors and implementation of angiotensin-converting enzyme inhibitors, β-blockers, coronary revascularization, implantable cardioverter-defibrillators, and cardiac resynchronization therapeutic strategies, the outcome often remains unsatisfactory. This evidence concerns the gene ACE and heart failure.